Please assess the completion status of the following clinical trial:

Trial Title: Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~For people with PTSD:~* Meets DSM-IV criteria for PTSD~* Medically healthy~* Right handed~* Learned English prior to age 5~* Agrees to use an effective form of contraception throughout the study~For healthy controls:~* Medically healthy~* Right handed~* Has experienced a qualifying traumatic event~* Does not meet DSM-IV criteria for present or past PTSD~* Learned English prior to age 5~* Agrees to use an effective form of contraception throughout the study~Exclusion Criteria:~For people with PTSD:~* Meets DSM-IV criteria for panic disorder within 6 months prior to study entry~* Current suicide risk~* History of DSM-IV diagnosis of any the following conditions: schizophrenia, bipolar mood disorder, obsessive compulsive disorder (including trichotillomania), or eating disorder~* Meets DSM-IV criteria for substance use or dependence within the 6 months prior to study entry~* Any substance abuse within 2 weeks prior to study entry~* Score of greater than 22 on the 17-item Hamilton Rating Scale for Depression (HAM-D) with depressive symptoms secondary to PTSD~* Current participation in cognitive behavioral psychotherapy that is specifically designed to treat PTSD~* Concomitant psychoactive medications~* History of cerebrovascular accident (CVA) or any disorder that causes chronic neurological problems~* Medical illness with central nervous system (CNS) involvement or currently taking medication that affects the CNS~* Unstable general medical illness requiring intervention (e.g., HIV infection)~* Pregnant, breastfeeding, or plans to become pregnant~* Presence of internal metallic objects, such as heart pacemaker, shrapnel, bullets, surgical prostheses, surgical clips, or pins~* History of gastric bypass surgery~For healthy controls:~* Any history of generalized anxiety disorder or panic disorder~* Any history of psychotic disorder, bipolar disorder, or cyclothymia~* Any history of substance abuse or dependence within the 6 months prior to study entry~* Any substance use within 2 weeks prior to study entry~* Any other Axis I disorder within the year prior to study entry, including obsessive-compulsive disorder and trichotillomania~* Unstable general medical illness requiring intervention (e.g., HIV infection)~* Presence of internal metallic objects, such as heart pacemaker, shrapnel, bullets, surgical prostheses, surgical clips, or pins~* Concomitant psychoactive medications~* Patients with a history of cerebrovascular accident (CVA) or any disorder that causes chronic neurological problems~* Medical illness with central nervous system (CNS) involvement or currently taking medication that affects the CNS~* Cognitive impairment or severe Axis II disorder that will likely affect participation in the study~* Pregnant, breastfeeding, or plans to become pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Control (Type: NO_INTERVENTION): Participants assigned to the control condition will receive no treatment
- Sertraline (Type: ACTIVE_COMPARATOR): Participants will receive treatment with sertraline
- CBT (Type: ACTIVE_COMPARATOR): Participants will receive cognitive behavioral therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues